Literature DB >> 2681425

An enzyme immunoassay to detect specific antibodies to protein and lipopolysaccharide antigens of Chlamydia trachomatis.

J M Ossewaarde1, J W Manten, H J Hooft, A C Hekker.   

Abstract

We have developed an enzyme immunoassay to measure antibodies to the proteins and lipopolysaccharide (LPS) of Chlamydia trachomatis. Antibodies to proteins could be differentiated from antibodies to lipopolysaccharide (LPS) by treatment of the antigen with periodate or Triton X-100. Some important parameters of the oxidation by periodate were studied by comparing the response of several monoclonal antibodies. Four types of response could be observed: type I, a reduced response after mild or strong oxidation; type II, a normal response after mild oxidation, but reduced after strong oxidation; type III, not affected; type IV, an increased response after oxidation. Treatment with Triton X-100 had the same effect as mild oxidation and confirmed the response types I, III, and IV. Treatment of antigen with periodate reduced the IgG response measured in sera from patients with evidence of Chlamydia psittaci infection.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2681425     DOI: 10.1016/0022-1759(89)90233-0

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  10 in total

1.  Chlamydia pneumoniae in vitro and in vivo: a critical evaluation of in situ detection methods.

Authors:  A Meijer; P J Roholl; S K Gielis-Proper; Y F Meulenberg; J M Ossewaarde
Journal:  J Clin Pathol       Date:  2000-12       Impact factor: 3.411

2.  Phase variation analysis of Coxiella burnetii during serial passage in cell culture by use of monoclonal antibodies.

Authors:  Akitoyo Hotta; Midori Kawamura; Ho To; Masako Andoh; Tsuyoshi Yamaguchi; Hideto Fukushi; Katsuya Hirai
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

3.  Comparison of two panels of monoclonal antibodies for determination of Chlamydia trachomatis serovars.

Authors:  J M Ossewaarde; M Rieffe; A de Vries; R P Derksen-Nawrocki; H J Hooft; G J van Doornum; A M van Loon
Journal:  J Clin Microbiol       Date:  1994-12       Impact factor: 5.948

4.  Coronary angioplasty induces rise in Chlamydia pneumoniae-specific antibodies.

Authors:  A Tiran; R A Tio; J M Ossewaarde; B Tiran; P den Heijer; T H The; M M Wilders-Truschnig
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

5.  No association of anti-Chlamydia trachomatis antibodies and severity of cervical neoplasia.

Authors:  N Reesink-Peters; J M Ossewaarde; A G Van Der Zee; W G Quint; M P Burger; A H Adriaanse
Journal:  Sex Transm Infect       Date:  2001-04       Impact factor: 3.519

6.  Chlamydia keratoconjunctivitis determination of Chlamydia trachomatis specific secretory immunoglobulin A in tears by enzyme immunoassay.

Authors:  N J Buisman; J M Ossewaarde; M Rieffe; A M van Loon; J S Stilma
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

7.  Genotyping of Chlamydia trachomatis serovars derived from heterosexual partners and a detailed genomic analysis of serovar F.

Authors:  J Lan; C J Meijer; A R van den Hoek; J M Ossewaarde; J M Walboomers; A J van den Brule
Journal:  Genitourin Med       Date:  1995-10

8.  Enzyme immunoassay with enhanced specificity for detection of antibodies to Chlamydia trachomatis.

Authors:  J M Ossewaarde; A de Vries; J A van den Hoek; A M van Loon
Journal:  J Clin Microbiol       Date:  1994-06       Impact factor: 5.948

9.  Low prevalence of Chlamydia pneumoniae and Mycoplasma pneumoniae among patients with symptoms of respiratory tract infections in Dutch general practices.

Authors:  A Meijer; C F Dagnelie; J C De Jong; A De Vries; T M Bestebroer; A M Van Loon; A I Bartelds; J M Ossewaarde
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

10.  Evaluation of an in silico predicted specific and immunogenic antigen from the OmcB protein for the serodiagnosis of Chlamydia trachomatis infections.

Authors:  Olfa Frikha-Gargouri; Radhouane Gdoura; Abir Znazen; Boutheina Gargouri; Jalel Gargouri; Ahmed Rebai; Adnene Hammami
Journal:  BMC Microbiol       Date:  2008-12-10       Impact factor: 3.605

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.